Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous RecipientsAlexander Nikoloudis, Johannes Clausen, David Nachbaur et al.|Transplantation and Cellular Therapy|2021Cited by 7
Adverse impact of a high<scp>CD4</scp>/<scp>CD8</scp>ratio in the allograft may be overcome by methotrexate‐ but not mycophenolate‐ or post‐transplant cyclophosphamide‐based graft versus host disease prophylaxisAlexander Nikoloudis, Johannes Clausen, Veronika Buxhofer‐Ausch et al.|European Journal Of Haematology|2023Cited by 5
Impact of the Recipient’s Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell TransplantationAlexander Nikoloudis, Johannes Clausen, Veronika Buxhofer‐Ausch et al.|Cells|2023Cited by 5
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysisAlexander Nikoloudis, Johannes Clausen, Veronika Buxhofer‐Ausch et al.|Cell Transplantation|2025Cited by 2
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic LeukemiaChristina Groiss, Johannes Clausen, Stefanie Kreissl et al.|Journal of Clinical Medicine|2025Cited by 1